[go: up one dir, main page]

AU5874798A - Vaccination methods and molecules - Google Patents

Vaccination methods and molecules

Info

Publication number
AU5874798A
AU5874798A AU58747/98A AU5874798A AU5874798A AU 5874798 A AU5874798 A AU 5874798A AU 58747/98 A AU58747/98 A AU 58747/98A AU 5874798 A AU5874798 A AU 5874798A AU 5874798 A AU5874798 A AU 5874798A
Authority
AU
Australia
Prior art keywords
molecules
vaccination methods
vaccination
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU58747/98A
Inventor
Frank Joseph Carr
Graham Carter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biovation Ltd
Original Assignee
Biovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9701999.6A external-priority patent/GB9701999D0/en
Priority claimed from GBGB9714182.4A external-priority patent/GB9714182D0/en
Priority claimed from GBGB9716641.7A external-priority patent/GB9716641D0/en
Priority claimed from GBGB9716620.1A external-priority patent/GB9716620D0/en
Priority claimed from GBGB9724584.9A external-priority patent/GB9724584D0/en
Application filed by Biovation Ltd filed Critical Biovation Ltd
Publication of AU5874798A publication Critical patent/AU5874798A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/19—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/24—Antigen-presenting cells [APC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/46—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2833—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0055—Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10)
    • C12N9/0057—Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10) with oxygen as acceptor (1.10.3)
    • C12N9/0059—Catechol oxidase (1.10.3.1), i.e. tyrosinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU58747/98A 1997-01-31 1998-02-02 Vaccination methods and molecules Abandoned AU5874798A (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
GBGB9701999.6A GB9701999D0 (en) 1997-01-31 1997-01-31 Vaccination method and molecules
GB9701999 1997-01-31
GB9714182 1997-07-05
GBGB9714182.4A GB9714182D0 (en) 1997-07-07 1997-07-07 Vaccination methods and molecules
GB9716620 1997-08-07
GBGB9716641.7A GB9716641D0 (en) 1997-08-07 1997-08-07 Vaccination methods and molecules
GBGB9716620.1A GB9716620D0 (en) 1997-08-07 1997-08-07 Nucleic acid vaccine molecules
GB9716641 1997-08-07
GB9724584 1997-11-21
GBGB9724584.9A GB9724584D0 (en) 1997-11-21 1997-11-21 Nucleic acid vaccine molecules
PCT/GB1998/000325 WO1998033523A1 (en) 1997-01-31 1998-02-02 Vaccination methods and molecules

Publications (1)

Publication Number Publication Date
AU5874798A true AU5874798A (en) 1998-08-25

Family

ID=27517396

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58747/98A Abandoned AU5874798A (en) 1997-01-31 1998-02-02 Vaccination methods and molecules

Country Status (2)

Country Link
AU (1) AU5874798A (en)
WO (1) WO1998033523A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9804065D0 (en) * 1998-02-26 1998-04-22 Cancer Res Campaign Tech Tumour associated antigen 791Tgp72
JP2003528573A (en) 1999-05-06 2003-09-30 ウエイク・フオレスト・ユニバーシテイ Compositions and methods for identifying antigens that elicit an immune response
BRPI0715794A2 (en) 2006-08-17 2013-07-23 Hoffmann La Roche ccr5 antibody conjugate and antifusogenic peptide
TW200817438A (en) 2006-08-17 2008-04-16 Hoffmann La Roche A conjugate of an antibody against CCR5 and an antifusogenic peptide
AR067584A1 (en) 2007-07-20 2009-10-14 Hoffmann La Roche A CONJUGATE OF AN ANTIBODY AGAINST CD4 AND ANTIFUSOGENIC PEPTIDES
JP5642549B2 (en) 2007-10-12 2014-12-17 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ Protein expression from multiple nucleic acids
JP5221673B2 (en) 2007-12-15 2013-06-26 エフ．ホフマン−ラ ロシュ アーゲー Identification assay
US8524470B2 (en) 2009-07-30 2013-09-03 Hoffman-La Roche, Inc. Enzymatic antibody processing
MX2012002030A (en) 2009-09-07 2012-03-16 Hoffmann La Roche Es-ms of glycopeptides for analysis of glycosylation.
KR101584416B1 (en) 2010-10-05 2016-01-13 에프. 호프만-라 로슈 아게 Antibodies against human tweak and uses thereof
ES2548215T3 (en) 2011-10-05 2015-10-14 F. Hoffmann-La Roche Ag Process for the production of G1 glycoform antibodies
EP2832854A1 (en) 2013-08-02 2015-02-04 F. Hoffmann-La Roche AG Method for improving the recombinant expression of a polypeptide by C-terminal fusion to human neprilysin
CN117887794A (en) 2016-12-21 2024-04-16 豪夫迈·罗氏有限公司 Methods for in vitro glycoengineering antibodies
WO2018114877A1 (en) 2016-12-21 2018-06-28 F. Hoffmann-La Roche Ag In vitro glycoengineering of antibodies
MX2019007411A (en) 2016-12-21 2019-08-29 Hoffmann La Roche Re-use of enzymes in in vitro glycoengineering of antibodies.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4587044A (en) * 1983-09-01 1986-05-06 The Johns Hopkins University Linkage of proteins to nucleic acids
US5635602A (en) * 1993-08-13 1997-06-03 The Regents Of The University Of California Design and synthesis of bispecific DNA-antibody conjugates

Also Published As

Publication number Publication date
WO1998033523A1 (en) 1998-08-06

Similar Documents

Publication Publication Date Title
AU8766098A (en) Assay methods and apparatus
AU9790198A (en) Compounds and methods
AU7275098A (en) Enhanced adenovirus-assisted transfection composition and method
AU7383398A (en) Therapeutic glasses and method for using the same
AU7161598A (en) Goniometer-based body-tracking device and method
AUPM392594A0 (en) Merchandising means and method
AU2238697A (en) Display arrangement and method
AU9781998A (en) Huchordin and uses thereof
AU8173098A (en) Neuroprotective methods and reagents
AU6667998A (en) Nucleic acids encoding caspase-8h and caspase-8i
AU2079397A (en) Improved connectors and methods
AU5874798A (en) Vaccination methods and molecules
AU1184399A (en) Therapeutic molecules
AU1990199A (en) Decoding method and apparatus
AU8225398A (en) Biosensor materials and methods
AU1664299A (en) Autodegradable microcarriers and their use
AU6084598A (en) Antibiotic-ligand conjugates and methods of use thereof
AUPP263498A0 (en) Novel therapeutic molecules and uses therefor
AU6601098A (en) Vaccine and assay
AU6750498A (en) Hexahydroaspartame amides and method for the preparation thereof
GB9716641D0 (en) Vaccination methods and molecules
GB9714182D0 (en) Vaccination methods and molecules
AUPO568697A0 (en) Merchandising apparatus and method
GB9701999D0 (en) Vaccination method and molecules
GB9701998D0 (en) Vaccination method and molecules